Scarica l'app Stockscreener
25.68
6.73%
1.62
Dopo l'orario di chiusura:
25.68
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$24.06
Aprire:
$24.29
Volume 24 ore:
701.13K
Relative Volume:
1.26
Capitalizzazione di mercato:
$1.23B
Reddito:
$151.91M
Utile/perdita netta:
$-46.03M
Rapporto P/E:
-25.43
EPS:
-1.01
Flusso di cassa netto:
$5.65M
1 W Prestazione:
+21.76%
1M Prestazione:
+16.99%
6M Prestazione:
-5.38%
1 anno Prestazione:
-3.17%
Intervallo 1D:
$24.04
$25.73
Intervallo di 1 settimana:
$20.27
$25.73
Portata 52W:
$19.10
$29.55
Biolife Solutions Inc Stock (BLFS) Company Profile
Nome
Biolife Solutions Inc
Settore
Industria
Telefono
(425) 401-1400
Indirizzo
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Confronta BLFS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BLFS
Biolife Solutions Inc
|
25.68 | 1.07B | 151.91M | -46.03M | 5.65M | -1.01 |
|
ISRG
Intuitive Surgical Inc
|
482.34 | 169.15B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
195.96 | 55.18B | 21.39B | 1.59B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
288.28 | 41.63B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
86.48 | 41.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
WST
West Pharmaceutical Services Inc
|
246.22 | 17.28B | 2.90B | 467.20M | 306.90M | 6.37 |
Biolife Solutions Inc Stock (BLFS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2024-09-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-04-04 | Iniziato | Jefferies | Buy |
| 2023-07-11 | Iniziato | Craig Hallum | Buy |
| 2022-04-25 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-10-19 | Iniziato | B. Riley Securities | Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-05-14 | Downgrade | The Benchmark Company | Buy → Hold |
| 2021-03-23 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-09-18 | Iniziato | Cowen | Outperform |
| 2020-08-11 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-07-08 | Reiterato | Maxim Group | Buy |
| 2020-02-24 | Iniziato | Lake Street | Buy |
| 2020-02-19 | Iniziato | The Benchmark Company | Buy |
| 2020-02-06 | Ripresa | B. Riley FBR | Buy |
| 2020-01-08 | Iniziato | Stephens | Overweight |
| 2019-11-21 | Iniziato | Oppenheimer | Outperform |
| 2019-07-22 | Iniziato | H.C. Wainwright | Buy |
| 2017-11-10 | Reiterato | Maxim Group | Buy |
| 2017-09-19 | Reiterato | Maxim Group | Buy |
| 2017-07-05 | Aggiornamento | Janney | Neutral → Buy |
| 2017-03-10 | Reiterato | Maxim Group | Buy |
| 2017-01-19 | Iniziato | Maxim Group | Buy |
Mostra tutto
Biolife Solutions Inc Borsa (BLFS) Ultime notizie
BioLife Solutions (BLFS) Upgraded to Strong Buy: Here's Why - MSN
BioLife (BLFS) Is Up 16.1% After Raising 2025 Guidance and Reporting Strong Q2 Results - simplywall.st
Wall Street Analysts Predict a 39.92% Upside in BioLife Solutions (BLFS): Here's What You Should Know - sharewise.com
BioLife Solutions Reports Strong Q2 Growth Amid Challenges - TipRanks
BioLife Solutions, Inc. (NASDAQ:BLFS) Q2 2025 Earnings Call Transcript - Insider Monkey
Analysts Weigh In on Green Thumb Industries, Doximity, and BioLife Solutions - AInvest
BioLife Solutions raises 2025 revenue guidance to $100M–$103M as cell processing momentum accelerates - MSN
BioLife Solutions Reports Strong Q2 2025 Growth - TipRanks
What You Can Learn From BioLife Solutions, Inc.'s (NASDAQ:BLFS) P/S - 富途牛牛
BioLife Solutions to Report Second Quarter 2025 Financial Results and Business Update on August 7, 2025 - goSkagit
Regression analysis insights on BioLife Solutions Inc. performanceAI Intraday Market Movement Prediction Tool - Newser
Will BioLife Solutions Inc. rebound enough to break evenWeekly Stock Market Strategy Summary - Newser
BioLife Solutions (NASDAQ:BLFS) Receives “Buy” Rating from HC Wainwright - Defense World
BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2 - MSN
A Quick Look at Today's Ratings for BioLife Solutions(BLFS.US), With a Forecast Between $30 to $32 - 富途牛牛
BioLife Solutions Receives Buy Rating from Northland Securities, Price Target at $31.00 - AInvest
BioLife Solutions (BLFS) Is Up 9.0% After Raising 2025 Revenue Outlook Has The Bull Case Changed? - simplywall.st
BioLife Solutions Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Is BioLife Solutions (NASDAQ:BLFS) A Risky Investment? - simplywall.st
BioLife Solutions (NASDAQ:BLFS) Trading 12.5% Higher on Analyst Upgrade - Defense World
How to use a screener to detect BioLife Solutions Inc. breakoutsDaily Trade Monitor with Pattern Alerts - Newser
Can you recover from losses in BioLife Solutions Inc.Smart Trade Forecast Based on Neural Logic - Newser
BioLife Solutions 2025 Q2 Earnings Loss Narrows 23.6% as Revenue Rises 28.9% - AInvest
BioLife Solutions Raises 2025 Revenue Guidance to $100M-$103M on Cell Processing Momentum - AInvest
BioLife Solutions: HC Wainwright Raises PT to $32, Maintains Buy Rating - AInvest
Earnings call transcript: BioLife Solutions Q2 2025 sees EPS miss, raises revenue guidance - Investing.com Nigeria
BioLife Solutions Inc reports results for the quarter ended June 30Earnings Summary - TradingView
BioLife Solutions: Strong Performance and Growth Potential with Buy Rating - TipRanks
BioLife Solutions: Strategic Reinvention and Growth in the Biopreservation Sector - AInvest
BioLife Solutions Updates 2025 Revenue Guidance to $100-103mln, Reflecting 22-25% YoY Growth - AInvest
BioLife Solutions earnings missed by $0.30, revenue topped estimates - Investing.com Canada
BioLife Solutions Q2 revenue up 28% YoY to $23mln, raises FY23 guidance. - AInvest
BioLife Solutions Reports Second Quarter 2025 Financial Results - TradingView
Earnings Flash (BLFS) BioLife Solutions, Inc. Reports Q2 Revenue $25.4M, vs. FactSet Est of $23.7M - MarketScreener
Market reaction to BioLife Solutions Inc.’s recent newsReliable Setup Screener with Low Risk - Newser
BioLife Solutions, Inc. (NASDAQ:BLFS) Receives Consensus Rating of “Buy” from Analysts - Defense World
BioLife Solutions BLFS 2025Q2 Earnings Preview Upside Anticipated on Robust Revenue Growth - AInvest
Is BioLife Solutions Inc. the Top Chart Pick This WeekEarly Breakout Entry Point Notifications Sent - beatles.ru
BioLife Solutions Inc. Approaches Psychological Resistance LevelDay Trading Signals With High Precision Reviewed - metal.it
How volatile is BioLife Solutions Inc. stock compared to the marketUnlock daily market insights for better trades - Jammu Links News
What makes BioLife Solutions Inc. stock price move sharplyExplosive earnings growth - Jammu Links News
Is BioLife Solutions Inc. stock overvalued or undervaluedMaximize portfolio growth with strategic plans - Jammu Links News
How many analysts rate BioLife Solutions Inc. as a “Buy”Build wealth with long-term growth strategies - Jammu Links News
What catalysts could drive BioLife Solutions Inc. stock higher in 2025Rapid profit acceleration - Jammu Links News
What are BioLife Solutions Inc. company’s key revenue driversFree Risk Assessment Services - Jammu Links News
Reversal indicators forming on BioLife Solutions Inc. stockReversal Pattern Insights with Entry Tips - Newser
BioLife Solutions Inc. Stock Analysis and ForecastBreakneck growth rates - Jammu Links News
Contrasting GlucoTrack (NASDAQ:GCTK) & BioLife Solutions (NASDAQ:BLFS) - Defense World
Candlestick signals on BioLife Solutions Inc. stock todayTechnical Screener for High Growth Stocks - Newser
Why is BioLife Solutions Inc. stock attracting strong analyst attentionInvest in stocks with strong fundamentals - Jammu Links News
Is BioLife Solutions Inc. a good long term investmentSpectacular growth rates - Jammu Links News
Biolife Solutions Inc Azioni (BLFS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):